Skip Navigation


Carcinogenesis Advance Access originally published online on May 23, 2007
Carcinogenesis 2007 28(8):1765-1773; doi:10.1093/carcin/bgm123
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/8/1765    most recent
bgm123v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sandur, S. K.
Right arrow Articles by Aggarwal, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sandur, S. K.
Right arrow Articles by Aggarwal, B. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism

Santosh K. Sandur, Manoj K. Pandey, Bokyung Sung, Kwang Seok Ahn, Akira Murakami1, Gautam Sethi, Pornngarm Limtrakul2, Vladimir Badmaev3 and Bharat B. Aggarwal*

Cytokine Research Section, Department of Experimental Therapeutics, Box 143, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
1 Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, 619-0237 Japan
2 Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
3 Sabinsa Corporation, Piscataway, NJ 08854, USA

* To whom correspondence should be addressed. Tel: +1 713 794 1817; Fax: +1 713 794 1613; Email: aggarwal{at}mdanderson.org

Curcumin, a component of turmeric (Curcuma longa), has been shown to exhibit chemopreventive activity. Whether analogs of curcumin (Cur), such as demethoxycurcumin (DMC), bisdemethoxycurcumin (BDMC), tetrahydrocurcumin (THC) and turmerones, modulate inflammatory signaling and cell proliferation signaling to same extent as curcumin was investigated. The results indicate that the relative potency for suppression of tumor necrosis factor (TNF)-induced nuclear factor-{kappa}B (NF-{kappa}B) activation was Cur > DMC > BDMC; thus suggesting the critical role of methoxy groups on the phenyl ring. THC, which lacks the conjugated bonds in the central seven-carbon chain, was completely inactive for suppression of the transcription factor. Turmerones also failed to inhibit TNF-induced NF-{kappa}B activation. The suppression of NF-{kappa}B activity correlated with inhibition of NF-{kappa}B reporter activity and with down-regulation of cyclooxygenase-2, cyclin D1 and vascular endothelial growth factor, all regulated by NF-{kappa}B. In contrast to NF-{kappa}B activity, the suppression of proliferation of various tumor cell lines by Cur, DMC and BDMC was found to be comparable; indicating the methoxy groups play minimum role in the growth-modulatory effects of curcumin. THC and turmerones were also found to be active in suppression of cell growth but to a much lesser extent than curcumin, DMC and BDMC. Whether suppression of NF-{kappa}B or cell proliferation, no relationship of any of the curcuminoid was found with reactive oxygen species (ROS) production. Overall, our results demonstrated that different analogs of curcumin present in turmeric exhibit variable anti-inflammatory and anti-proliferative activities, which do not correlate with their ability to modulate the ROS status.

Abbreviations: ar-turmerone, aromatic turmerone; BDMC, bisdemethoxycurcumin; COX-2, cyclooxygenase-2; Cur, pure curcumin; DCF-DA, dichlorodihydrofluorescein diacetate; DMC, demethoxycurcumin; FBS, fetal bovine serum; GSH, glutathione; HPLC, high-performance liquid chromatography; NF-{kappa}B, nuclear factor-{kappa}B; ROS, reactive oxygen species; THC, tetrahydrocurcumin; THF, tetrahydrofuran; TLC, thin-layer chromatography; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor

Received March 20, 2007; revised May 14, 2007; accepted May 14, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. K. Vareed, M. Kakarala, M. T. Ruffin, J. A. Crowell, D. P. Normolle, Z. Djuric, and D. E. Brenner
Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects
Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1411 - 1417.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y.-J. Choi, H.-S. Lim, J.-S. Choi, S.-Y. Shin, J.-Y. Bae, S.-W. Kang, I.-J. Kang, and Y.-H. Kang
Blockade of Chronic High Glucose-Induced Endothelial Apoptosis by Sasa borealis Bamboo Extract
Experimental Biology and Medicine, May 1, 2008; 233(5): 580 - 591.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.